至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Pyruvate kinase type M2 promotes tumour cell exosome release via phosphorylating synaptosome-associated protein 23.

Nat Commun. 2017; 
WeiYao,WangDong,JinFangfang,BianZhen,LiLimin,LiangHongwei,LiMingzhen,ShiLei,PanChaoyun,ZhuDihan,ChenXi,HuGang,LiuYuan,ZhangChen-Yu,Z
Products/Services Used Details Operation
Custom Vector Construction Specific siRNAs against PKM1 (50-GCGUGGAGGCUUCUUAUAA-30), PKM2 (50-CCAUAAUCGUCCUCACCAA-30) and SNAP-23 (50-CCAACAGAGAUCGU AUUGA-30) were purchased from RIBOBIO (Guangzhou, China). Recombinant SNAP-23 and expression vectors of wide type/mutant SNAP-23 were synthesized and purchased from Genscript (Nanjing, China). Get A Quote

摘要

Tumour cells secrete exosomes that are involved in the remodelling of the tumour-stromal environment and promoting malignancy. The mechanisms governing tumour exosome release, however, remain incompletely understood. Here we show that tumour cell exosomes secretion is controlled by pyruvate kinase type M2 (PKM2), which is upregulated and phosphorylated in tumours. During exosome secretion, phosphorylated PKM2 serves as a protein kinase to phosphorylate synaptosome-associated protein 23 (SNAP-23), which in turn enables the formation of the SNARE complex to allow exosomes release. Direct phosphorylation assay and mass spectrometry confirm that PKM2 phosphorylates SNAP-23 at Ser95. Ectopic expression of ... More

关键词